Pyronaridine Tetraphosphate

DRUG2 trials

Sponsors

Medicines for Malaria Venture, Armaceutica, Inc.

Conditions

Acute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)Healthy

Phase 1

A Healthy Volunteer Safety Study of Pyronaridine Tetraphosphate Taken in Combination With Piperaquine Tetraphosphate

CompletedNCT05160363

Medicines for Malaria VentureHealthy

Start: 2022-02-14End: 2022-05-31Updated: 2024-05-10

Phase 2

Pyronaridine in Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML)

Armaceutica, Inc.Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML)

Start: 2022-11-21End: 2024-03-31Target: 200Updated: 2022-11-29

Related Papers

Concentration–Response Analysis of the Combination of Pyronaridine and Piperaquine on Corrected <scp>QT</scp> Interval From a Randomized, Double‐Blind, Placebo‐Controlled Study in Healthy Adults of African Sub‐Saharan Origin

Clinical and Translational Science2025-07-01